Angiolab, Inc. (XKON:251280)
South Korea · Delayed Price · Currency is KRW 2,490.00
+290.00 (13.18%)
At close: Oct 23, 2026
Angiolab Market Cap
Angiolab has a market cap or net worth of 8.69 billion as of October 23, 2026. It is the 43,634th most valuable company in the world and the 2,651st biggest in South Korea. Its market cap has decreased by 40.57% in one year.
Market Cap
8.69B
Enterprise Value
n/a
Revenue
702.62M
Global Rank
Country Rank
#2,651 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 5, 2017, Angiolab's market cap has increased from 8.46B to 8.69B, an increase of 2.77%. That is a compound annual growth rate of 0.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 8.69B | 1.22% |
| Dec 30, 2025 | 8.59B | -62.64% |
| Dec 30, 2024 | 22.99B | 34.78% |
| Dec 28, 2023 | 17.06B | -12.06% |
| Dec 29, 2022 | 19.40B | -6.10% |
| Dec 30, 2021 | 20.66B | -31.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| Progen | 31.44B |
| Shaperon | 21.60B |
| Poongjeon Pharmacy CO.,LTD. | 20.11B |
| Moogene Medi | 18.85B |
| Plumbline Life Sciences | 18.69B |
| NGeneBio | 11.26B |